Provided by Tiger Fintech (Singapore) Pte. Ltd.

Compass Therapeutics, Inc.

1.75
+0.05002.94%
Post-market: 1.760.0100+0.57%19:27 EDT
Volume:691.69K
Turnover:1.20M
Market Cap:241.99M
PE:-4.87
High:1.78
Open:1.69
Low:1.68
Close:1.70
Loading ...

Compass Therapeutics Inc. - Top-Line Phase 2/3 Data for Tovecimig Expected End of Q1 2025

THOMSON REUTERS
·
08 Jan

Compass Therapeutics Inc. - Two Phase 2 Biomarker Trials Expected to Initiate Mid-2025

THOMSON REUTERS
·
08 Jan

Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug Candidate

THOMSON REUTERS
·
08 Jan

Compass Therapeutics: Estimates $127 Mln in Cash & Marketable Securities at Ye 2024, Which Is Expected to Provide Cash Runway Into Q1 2027

THOMSON REUTERS
·
08 Jan

Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug Candidate

GlobeNewswire
·
08 Jan

US Penny Stocks To Watch In January 2025

Simply Wall St.
·
08 Jan

Compass Therapeutics Names Barry Shin CFO

MT Newswires Live
·
10 Dec 2024

Is Compass Therapeutics, Inc. (CMPX) Stock Outpacing Its Medical Peers This Year?

Zacks
·
10 Dec 2024

Compass Therapeutics Names Barry Shin Chief Financial Officer

Dow Jones
·
10 Dec 2024

Compass Therapeutics appoints Shin as Chief Financial Officer

TIPRANKS
·
10 Dec 2024

Compass Therapeutics Inc - Barry Shin Replaces Thomas Schuetz as Principal Financial Officer

THOMSON REUTERS
·
10 Dec 2024

Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer

THOMSON REUTERS
·
10 Dec 2024

Press Release: Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer

Dow Jones
·
10 Dec 2024

Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire
·
02 Dec 2024

Compass downgrade ‘curious,’ presents upside, says H.C. Wainwright

TIPRANKS
·
16 Nov 2024

BUZZ-Leerink Partners cuts Compass Therapeutics to 'market perform'

Reuters
·
15 Nov 2024

Compass Therapeutics Inc. : Leerink Partners Cuts to Market Perform From Outperform

THOMSON REUTERS
·
15 Nov 2024

Compass Therapeutics downgraded to Market Perform from Outperform at Leerink

TIPRANKS
·
15 Nov 2024

Compass Therapeutics Reports Q3 2024 Financials and Clinical Progress

TIPRANKS
·
14 Nov 2024

Compass Therapeutics to Participate in Upcoming Investor Events

GlobeNewswire
·
13 Nov 2024